A. Rosell

发表

Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity

J. Montaner, T. Iglesias, A. Gamir-Morralla, 2015, Cell Death and Disease.

Decreased Levels of Angiogenic Growth Factors in Intracranial Atherosclerotic Disease despite Severity-Related Increase in Endothelial Progenitor Cell Counts

J. Arenillas, C. Molina, J. Montaner, 2013, Cerebrovascular Diseases.

Chronic myeloid leukemia with expression of ALL-type BCR/ABL transcript: a case-report and review of the literature.

E. Lerma, P. Bolufer, E. Barragán, 1999, Leukemia research.

Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage

J. Arenillas, C. Molina, J. Montaner, 2006, Neurology.

CCL23: a new CC chemokine involved in human brain damage

J. Montaner, A. Rosell, A. Rosell, 2018, Journal of internal medicine.

Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients

Á. Payer, M. Ramírez, A. Rosell, 2018, Annals of Hematology.

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

M. Ramírez, A. Rosell, F. Sánchez-Guijo, 2021, Blood Cancer Journal.

Safety and ef ﬁ cacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

M. Ramírez, A. Rosell, F. Sánchez-Guijo, 2021 .

Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

E. González-Barca, C. Solano, A. Rosell, 2011, Expert review of hematology.

Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis

A. Rosell, J. Díez, M. Morado, 2015, Annals of Hematology.

Comparison Between Lymphoglobuline- and Thymoglobuline-Based Immunosuppressive Therapy as First-Line Treatment for Patients with Aplastic Anemia.

E. Colado, A. Rosell, S. Brunet, 2009 .

Osteopontin predicts long-term functional outcome among ischemic stroke patients

J. Montaner, J. Álvarez-Sabín, I. Férnandez-Cadenas, 2011, Journal of Neurology.

Update on the SerumBiomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients

J. Montaner, I. Férnandez-Cadenas, A. Rosell, 2014 .

Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients

J. Montaner, I. Férnandez-Cadenas, A. Rosell, 2011, Stroke research and treatment.

Leukoaraiosis is associated with genes regulating blood–brain barrier homeostasis in ischaemic stroke patients

C. Molina, J. Montaner, J. Álvarez-Sabín, 2011, European journal of neurology.

Brain Natriuretic Peptide Is Associated with Worsening and Mortality in Acute Stroke Patients but Adds No Prognostic Value to Clinical Predictors of Outcome

P. Delgado, C. Molina, J. Montaner, 2012, Cerebrovascular Diseases.

A panel of biomarkers including caspase‐3 and D‐dimer may differentiate acute stroke from stroke‐mimicking conditions in the emergency department

J. Montaner, J. Álvarez-Sabín, I. Férnandez-Cadenas, 2011, Journal of internal medicine.

Safety and Efficacy Profile of Asciminib As Treatment in Chronic Myeloid Leukemia Patients after Several Tyrosine-Kinase Inhibitors Failure

M. Ramírez, A. Rosell, F. Sánchez-Guijo, 2020 .

Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound.

J. Montaner, J. Álvarez-Sabín, L. Badimón, 2006, Atherosclerosis.

À. Rovira, C. Molina, J. Montaner, 2008, Neuroscience Letters.

Influence of thrombin‐activatable fibrinolysis inhibitor and plasminogen activator inhibitor‐1 gene polymorphisms on tissue‐type plasminogen activator‐induced recanalization in ischemic stroke patients

J. Montaner, J. Álvarez-Sabín, I. Férnandez-Cadenas, 2007, Journal of thrombosis and haemostasis : JTH.

Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

A. Rosell, L. Villalón, N. de Las Heras, 2022, Annals of Hematology.

The gender gap in stroke: a meta‐analysis

J. Montaner, A. Rosell, A. Rosell, 2012, Acta neurologica Scandinavica.

[ApoE genotype influences on efficacy and safety of thrombolytic treatment for ischemic stroke].

C. Molina, J. Montaner, I. Férnandez-Cadenas, 2006, Neurologia.

PAI-1 4G/5G Polymorphism is Associated with Brain Vessel Reocclusion After Successful Fibrinolytic Therapy in Ischemic Stroke Patients

C. Molina, J. Montaner, J. Álvarez-Sabín, 2010, The International journal of neuroscience.